MEETINGS & EVENTS
KDIGO BP Controversies Conference
KDIGO Controversies Conference Blood Pressure in Dialysis Patients
Kidney Disease: Improving Global Outcomes (KDIGO®) hosted a two-day controversies conference on “Blood Pressure in Chronic Kidney Disease Stage 5/ Dialysis Patients” in New York City. Fifty nephrologists, cardiologists, and researchers participated in the conference, which began with plenary session presentations reviewing the newest research on the evaluation, natural history, pathophysiology, and clinical management of blood pressure in patients receiving renal replacement therapy. The presentations were followed by focused discussion groups and a consensus-building process resulting in recommendations that will be published in a position statement.
A primary goal of the conference was to review the quality of the available evidence and make a recommendation to KDIGO on the validity and usefulness of developing a clinical practice guideline in this area. The group was also asked to determine if consensus could be reached on specific clinical recommendations that could be included in a position statement and, maybe most importantly, were challenged to outline and prioritize specific research projects that would be most valuable in expanding our knowledge in how to manage blood pressure in CKD Stage 5D.
“What will be the outcome of our gathering?,” asked the KDIGO co-chair and conference leader, Bertram Kasiske, MD during his opening speech. “Will we send a message to clinicians to improve patient outcomes with recommendations, or will we call for more research, or will we decide it is time to update or begin working on a new clinical practice guideline?”
The sessions were moderated by conference co-chairs, Nathan Levin, MD of the Renal Research Institute in New York City and Gérard London, MD of Centre Hospitalier Manhes in Fleury-Mérogis, France.
The full agenda for the conference can be found here. The plenary session presentations included:
- Natural history of low systolic blood pressure and blood pressure changes as an indication of future morbid events.
Peter Kotanko, MD
- Hypertension, diabetes, chronic kidney disease and carotid-intima media damage; methods for identification, prophylaxis and management. Blood vessel damage and hypertension; how best to assess endothelial dysfunction? ( 2.82MB)
Gérard London, MD
- BP measurement, interdialytic hypertension and the role of salt. ( 13.5MB)
Rajiv Agarwal, MD
- What is known from clinical trials about optimal drug management of hypertension in CKD Stage V – the role of beta blockers, and various forms of inhibition of the RAAS?
Hermann Haller, MD
- How best to control salt overload in hypertension? Dietetic? Aligning dialysate sodium with patient's serum sodium, prohibition of sodium profiling. ( 5.53KB)
Ken Farrington, MD
- Non-osmotic sodium in the body; significance and management.
Jens Titze, MD
- Hypertension and raised hematocrit, relationship to EPO and volume contraction
Kai-Ewe Eckardt, MD
- Hypertension and sleep apnea in CKD Stage 5 ( 5.3MB)
Chris Chan, MD
“We are impressed with the focused and productive dialogue that this distinguished group of international experts engaged in during the conference,” said Kai-Uwe Eckardt, KDIGO Co-Chair. “The recommendations that evolved from the discussions will be very valuable for the nephrology community and for the KDIGO Board to consider in planning for future clinical practice guidelines.
Look for the recommendations from the conference to be published in Kidney International in the next year.
The next KDIGO controversies conference will be held in the fall of 2009 to address the topic of “Chronic Kidney Disease: Definition, Classification and Prognosis.”
New York, NY
March 14-15, 2009
Nathan Levin –
Renal Research Institute
New York, USA
Gérard London –
Centre Hospitalier Manhes
Bertram Kasiske –
Hennepin County Medical Center
Kai-Uwe Eckardt –
University Hospital Erlangen
Peter de Leeuw